pyrazole has been researched along with Central Nervous System Toxoplasmosis in 1 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rutaganira, FU | 1 |
| Barks, J | 1 |
| Dhason, MS | 1 |
| Wang, Q | 1 |
| Lopez, MS | 1 |
| Long, S | 1 |
| Radke, JB | 1 |
| Jones, NG | 1 |
| Maddirala, AR | 1 |
| Janetka, JW | 1 |
| El Bakkouri, M | 1 |
| Hui, R | 1 |
| Shokat, KM | 1 |
| Sibley, LD | 1 |
1 other study available for pyrazole and Central Nervous System Toxoplasmosis
| Article | Year |
|---|---|
Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.
Topics: Animals; Antiprotozoal Agents; Female; Humans; Male; Mice; Protein Kinase Inhibitors; Protein Kinase | 2017 |